Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Mazdutide 5mg | 10-Vial Kit | 50mg Total | GLP-1/GCGR Dual Agonist
AsiaChinaWeight Loss & Metabolic

Mazdutide 5mg | 10-Vial Kit | 50mg Total | GLP-1/GCGR Dual Agonist

$230

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

China Warehouse Mazdutide 5mg — dual GLP-1R/GCGR agonist, Phase 3 weight loss compound. ≥99% HPLC, Janoshik COA. 10-vial kit. Research use only. International shipping: 7–14 days

SKU
VES-MDT5-MAZDUTIDE-5MG-10VIAL
Format
0.5 lbs
Use
Laboratory research only
Ask on Telegram

What is Mazdutide 5mg?

Mazdutide (IBI362) is a weekly dual GLP-1R/GCGR (glucagon receptor) agonist developed by Innovent Biologics. The GLP-1R component provides appetite suppression and insulin secretion; the GCGR component adds direct hepatic fat mobilisation, thermogenesis via brown adipose tissue activation, and energy expenditure enhancement. Phase 3 GLORY trials in Chinese populations showed superior weight reduction vs semaglutide alone, with additional NAFLD benefit via the glucagon axis. Represents the same mechanistic approach as retatrutide’s GCGR component in a dual (rather than triple) agonist framework.

Research Applications

Dual GLP-1/GCGR Agonism Research

Enables isolation of GCGR contribution to weight loss when combined with GLP-1R agonism — comparison with GLP-1 monotherapy reveals additive glucagon receptor effects on fat mass, hepatic lipid, and energy expenditure.

NASH/NAFLD Research

The GCGR component provides direct hepatic fat mobilisation — mazdutide is studied in NAFLD models where glucagon axis activation reduces liver TG independently of appetite effects.

Comparison vs Semaglutide/Tirzepatide

Phase 3 data positions mazdutide as a distinct dual-agonist comparator. Research comparing GLP-1 mono vs GLP-1+GIP vs GLP-1+GCGR informs next-generation obesity pharmacology.

Quick Specs

Product Mazdutide 5mg × 10 Vials (50mg total)
Also known as IBI362
Target GLP-1R + GCGR dual agonist
Format Lyophilised powder, 10-vial kit
Purity ≥99% HPLC, MS confirmed
Storage −20°C lyophilised; 4°C reconstituted

Certificate of Analysis (COA)

Frequently Asked Questions

How do I reconstitute this peptide?
Add 1–2mL bacteriostatic water to the lyophilized vial by directing water down the inner wall of the vial. Swirl gently until the powder fully dissolves — do not shake or vortex. The solution should be clear and colourless. Use immediately or refrigerate at 2–8°C.
How should this peptide be stored?
Store lyophilized peptide vials at −20°C for long-term storage. Once reconstituted, store at 2–8°C (refrigerator) and use within 21–28 days. Avoid repeated freeze-thaw cycles, direct light, and heat exposure.
What purity is this Vesta compound and how is it verified?
All Vesta compounds are tested to ≥99% purity by HPLC peak area analysis on every production batch. Molecular identity is confirmed by mass spectrometry. A Certificate of Analysis (COA) is published on the product page and independently verifiable at verify.janoshik.com using the batch reference number.
Peptide Research Tools: Use Vesta’s free peptide calculators — reconstitution, BAC water, dosing, half-life, and mixing charts.
International shipping: 7–14 days
Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.